|
Symbol
|
YOTLTQ | LTHCLK | AAIETQ | AAXSTQ | ABSFTQ | CQWBKB | LXWCLK | SKS6LK | QDPRCH | ADRATQ | LZQRCH | ADSXTQ | RMBU5V | AECRTQ | RMBFBV | AERWTQ | LHEHLK | RMBZJV | MATDJB | RQCRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Worst of Callable Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Reverse Convertible | LUKB Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Multi Vonti | Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Multi Vonti | Callable Multi Reverse Convertible | Worst of Callable Reverse Convertible |
|
Basiswert
|
Nestlé S.A. / Novartis AG / Roche PS | ABB / Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG | Nestlé S.A. / Novartis AG / Roche PS | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Lonza Group N / Novartis AG / Roche PS / Straumann Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N | Galderma Group AG / Novartis AG / Sika AG | Nestlé S.A. / Novartis AG / Roche PS / Zurich Insurance Group AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Givaudan / Novartis AG / Sandoz Group AG | Nestlé S.A. / Novartis AG / Roche PS | Lonza Group N / Novartis AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / Zurich Insurance Group AG | Kühne & Nagel Intl. AG / Novartis AG / Sika AG | Novartis AG / Roche PS / Sanofi S.A. | Nestlé S.A. / Novartis AG / Roche PS / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS | Logitech International SA / Nestlé S.A. / Novartis AG / Roche PS |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
24.11.2026 | 09.07.2027 | 19.07.2027 | 13.09.2027 | 20.12.2027 | 13.03.2028 | 25.03.2027 | 07.04.2027 | 16.05.2028 | 04.08.2028 | 07.08.2029 | 11.08.2028 | 22.02.2027 | 25.09.2028 | 04.10.2027 | 01.12.2027 | 15.12.2028 | 20.12.2027 | 10.01.2028 | 02.11.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
74.2425 | 58.7776 | 52.063 | 43.77 | 37.59 | 78.705 | 76.296 | 174.48 | 65.7375 | 35.72 | 2'627.25 | 46.384 | 292.70 | 281.20 | 130.88 | 60.487 | 58.7475 | 24.03 | 59.055 | 75.166 |
|
Maximal- rendite p.a. |
- | 4.71% | -0.68% | 1.59% | 1.90% | 6.01% | 3.00% | 13.84% | 4.86% | 3.43% | 4.28% | 1.68% | 1.04% | 2.95% | 3.15% | 5.47% | 5.64% | 3.89% | 5.09% | 4.21% |
| Geld | - | - | 101.57 | 101.22 | 100.84 | 98.80 | - | - | 99.12 | 98.99 | 99.69 | 101.34 | 100.10 | 99.97 | 99.70 | 100.98 | - | 99.60 | - | 99.42 |
| Brief | - | - | 102.44 | 102.08 | 101.70 | 99.65 | - | - | 99.97 | 99.84 | 100.54 | 102.21 | 101.50 | 100.82 | 100.70 | 101.84 | - | 100.60 | - | 100.27 |